Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation and Hemorrhagic Disorders”

2,037 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,037 results

Large-scale testing (Phase 3)Study completedNCT01568580
What this trial is testing

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Green Cross Corporation 71
Not applicableStudy completedNCT00195442
What this trial is testing

Study Evaluating Refacto For Pharmacovigilance

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 288
Not applicableUnknownNCT05981313
What this trial is testing

Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia

Who this might be right for
HemophiliaHemophilia AHemophilia B
Hasan Kalyoncu University 40
Not applicableUnknownNCT01538160
What this trial is testing

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

Who this might be right for
Hemophilia C
Sheba Medical Center 15
Early research (Phase 1)UnknownNCT02888223
What this trial is testing

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 16
Not applicableStudy completedNCT03355742
What this trial is testing

XIENCE 28 Global Study

Who this might be right for
Bleeding DisorderStroke, IschemicStroke Hemorrhagic+6 more
Abbott Medical Devices 963
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Not applicableStudy completedNCT06212505
What this trial is testing

EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURE

Who this might be right for
Hemophilia a
Hospices Civils de Lyon 6
Large-scale testing (Phase 3)Study completedNCT00157105
What this trial is testing

Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery

Who this might be right for
Hemophilia A
Baxalta now part of Shire 59
Large-scale testing (Phase 3)Looking for participantsNCT06833983
What this trial is testing

To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A

Who this might be right for
Hemophilia A
Gritgen Therapeutics Co., Ltd. 50
Post-approval studies (Phase 4)UnknownNCT05311930
What this trial is testing

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69
Testing effectiveness (Phase 2)Study completedNCT00111475
What this trial is testing

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 45
Large-scale testing (Phase 3)Study completedNCT04516967
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 75
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Not applicableWithdrawnNCT02726139
What this trial is testing

Improved Factor VIII Inhibitor Evaluation

Who this might be right for
HemophiliaHemophilia A
Boston VA Research Institute, Inc.
Not applicableStudy completedNCT01719692
What this trial is testing

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Not applicableStudy completedNCT03956836
What this trial is testing

Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Coagulation DisorderCarcinomatosis
Hospitales Universitarios Virgen del Rocío 46
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Testing effectiveness (Phase 2)Study completedNCT00487656
What this trial is testing

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

Who this might be right for
SepsisDisseminated Intravascular Coagulation
Artisan Pharma, Inc. 750
Next Page